🧬 Cagrilintide + Semaglutide – Research Peptide Blend

🧬 Product Overview

Cagrilintide + Semaglutide is a dual-compound research blend combining two peptides widely studied for their roles in appetite regulation and metabolic signaling. This combination targets complementary pathways involved in energy balance, making it a subject of increasing interest in advanced metabolic and weight regulation research.

Semaglutide, a GLP-1 receptor agonist, is studied for its effects on glucose metabolism and appetite signaling, while Cagrilintide, an amylin analog, is explored for its role in satiety and gastric emptying. Together, this blend is frequently examined for its synergistic interaction in metabolic studies.

🔬 Key Research Applications

Studies on appetite regulation and satiety signaling
Research into GLP-1 receptor and amylin pathway interactions
Investigation of metabolic function and energy balance
Exploration of gastric emptying and nutrient intake behavior
Cellular studies related to weight regulation mechanisms

This combination is commonly used in experimental models examining how dual-pathway targeting may influence metabolic outcomes.

⚗️ Product Specifications

Purity: ≥ 99% (HPLC tested)
Form: Lyophilized peptide blend
Appearance: White/off-white powder
Quantity: [5mg/5mg or 10mg/10mg]
Storage: Store in a cool, dry environment (2–8°C recommended)

🧪 Reconstitution & Handling

This peptide blend should be reconstituted using bacteriostatic water under sterile laboratory conditions. Proper handling procedures must be followed to maintain compound stability and prevent degradation.

🚚 Packaging & Quality Assurance

Each vial is:

Manufactured under strict quality control standards
Tested for purity, identity, and blend consistency
Securely sealed and packaged to ensure safe delivery

⚠️ Important Disclaimer

This product is intended for research purposes only.
Not for human consumption, medical, or diagnostic use.

cagrilintide+Semaglutide